Treatment of Heart Failure with Sodium-glucose Cotransporter Type 2 Inhibitors
Heart failure is a chronic disease that affects millions of people worldwide and is a leading cause of death. Sodium-glucose cotransporter type 2 inhibitors are a new class of drugs that have demonstrated cardiovascular benefits in patients with type 2 diabetes. The aim of the research was to gain i...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Espanhol |
| Argitaratua: |
Centro Provincial de Información de Ciencias Médicas. Cienfuegos
2024-09-01
|
| Saila: | Medisur |
| Gaiak: | |
| Sarrera elektronikoa: | http://medisur.sld.cu/index.php/medisur/article/view/45262 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|